Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Viracta Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.65
30.11.20
€10.50
30.11.21
-21.05%
14.12.20

Innovative
Could be worthwhile Investment >10% per year
Good culture
No uniques
me8 
30.11.20 50%
buy
Oramed Pharmaceuticals

Start price
Target price
Perf. (%)
€6.18
30.11.20
€8.00
30.11.21
-22.65%
30.11.20

Could be worthwhile Investment >10% per year
Fair valuation
Capable Management
Risky balance sheet
me8 
30.11.20 50%
sell
Evolus Inc

Start price
Target price
Perf. (%)
€3.15
30.11.20
-
-0.54%
14.12.20

Risky Investment
blaugold 
30.11.20 50%
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€10.60
29.11.20
€12.00
29.11.21
-11.79%
10.12.20

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
29.11.20 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€25.50
29.11.20
-
29.11.21
20.04%
24.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
FXX 
29.11.20 50%
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€19.50
28.11.20
€23.00
28.11.21
-36.41%
01.11.21

Could be worthwhile Investment >10% per year
melinda 
28.11.20 50%
buy
Axonics Modulation Technologies Inc

Start price
Target price
Perf. (%)
€37.20
28.11.20
€42.00
28.11.21
31.72%
29.11.21

Could be worthwhile Investment >10% per year
melinda 
28.11.20 50%
buy
Shanghai Fosun Pharmaceutical Group Co Ltd

Start price
Target price
Perf. (%)
€3.58
28.11.20
-
28.11.21
29.47%
29.11.21

Could be worthwhile Investment >10% per year
Known brand
Maxfloh 
28.11.20 50%
buy
Veeva Systems A

Start price
Target price
Perf. (%)
€230.05
28.11.20
-
28.11.21
12.50%
29.11.21

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Medium risks for its business
Maxfloh 
28.11.20 50%
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€40.23
26.11.20
€45.00
3.13%
08.12.20

Traumtanz 
26.11.20 50%
buy
Nanorepro AG

Start price
Target price
Perf. (%)
€3.38
26.11.20
-
16.11.21
198.22%
17.11.21

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
Lower EBIT Margin than peer group
Amped 
26.11.20 0%
sell
Cocrystal Pharma Inc.

Start price
Target price
Perf. (%)
€13.68
24.11.20
-
24.11.21
-18.86%
02.06.21

Probably not worthwhile Investment
stratec 
24.11.20 50%
buy
Novartis AG ADR

Start price
Target price
Perf. (%)
€74.00
24.11.20
€92.00
24.11.21
-1.08%
25.11.21

marge 
24.11.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€442.80
23.11.20
€555.00
23.11.21
29.97%
24.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
geldnutzer 
23.11.20 80%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€485.05
23.11.20
€770.00
07.07.23
39.47%
25.05.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
RudolfL 
23.11.20 60%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€450.00
-25.76%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Traumtanz 
22.11.20 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€48.20
22.11.20
€73.00
22.11.21
-0.41%
23.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Very high dividend yield expected
Konrad 
22.11.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

marge 
22.11.20 50%
sell
Inovio Pharma

Start price
Target price
Perf. (%)
€8.95
21.11.20
-
21.11.21
28.49%
10.02.21

Could be worthwhile Investment >10% per year
High risks for its business
Dependend from few customers or products
Washer 
21.11.20 50%
buy
Teleflex Inc.

Start price
Target price
Perf. (%)
€308.00
20.11.20
-
20.11.21
8.44%
14.02.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
CrazyEights 
20.11.20 50%
sell
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€437.60
19.11.20
€426.00
19.11.21
1.19%
23.11.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
geldnutzer 
19.11.20 50%
buy
Kazia Therapeutics ADR

Start price
Target price
Perf. (%)
€10.50
19.11.20
-
19.11.21
-28.57%
19.11.21

Risky Investment
Langfinger 
19.11.20 50%
buy
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€42.00
19.11.20
€50.00
19.11.21
-67.07%
07.11.21

Could be very worthwhile Investment >20% year
marge 
19.11.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.40
18.11.20
-
18.11.21
45.06%
19.11.21

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Low dividend yield expected
shadow 
18.11.20 50%
buy
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€32.66
18.11.20
€60.00
18.11.21
-3.60%
30.11.20

Could be worthwhile Investment >10% per year
DomRuinart 
18.11.20 50%